Page last updated: 2024-12-07

leukogen

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID101105
MeSH IDM0041273

Synonyms (26)

Synonym
AC-15737
STL356027
leucogen
nsc400257
1950-36-3
nsc-400257
2-(2-ethoxy-2-oxo-1-phenylethyl)-1,3-thiazolidine-4-carboxylic acid
leukogen
leucoson
2-thiazolidineacetic acid, 4-carboxy-alpha-phenyl-, 2-ethyl ester
2-thiazolidineacetic acid, 4-carboxy-alpha-phenyl-, alpha-ethyl ester
ethyl-4-carboxy alpha-phenyl-1,2-thiazolidine acetate
5zb58o726v ,
unii-5zb58o726v
nsc 400257
leyk
FT-0603580
AKOS015897259
leucogen [who-dd]
BBL023136
2-(2-ethoxy-2-oxo-1-phenylethyl)thiazolidine-4-carboxylic acid
VS-07334
DTXSID20941264
nsc400257; leukogen
Q27263098
STARBLD0016636

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"To investigate whether it is safe to use leucogen tablets 60 mg three times per day (180 mg for a day) and whether this regimen could reduce the incidence of febrile neutropenia caused by chemotherapy."( Leucogen tablets at 60 mg three times per day are safe and effective to control febrile neutropenia.
Cao, J; Huang, XE; Liu, J; Qian, ZY; Shi, L; Wang, L; Wu, XY; Xu, X, 2014
)
0.4
" Treatment-emergent adverse events were attributable to complications of myelosuppressive chemotherapy or the primary disease (i."( Leucogen tablets at 60 mg three times per day are safe and effective to control febrile neutropenia.
Cao, J; Huang, XE; Liu, J; Qian, ZY; Shi, L; Wang, L; Wu, XY; Xu, X, 2014
)
0.4
"This study suggested that leucogen tablets 60mg three times per day (180mg for a day) are safe and could be effective for preventing febrile neutropenia in patients with chemotherapy."( Leucogen tablets at 60 mg three times per day are safe and effective to control febrile neutropenia.
Cao, J; Huang, XE; Liu, J; Qian, ZY; Shi, L; Wang, L; Wu, XY; Xu, X, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (50.00)18.7374
1990's1 (10.00)18.2507
2000's2 (20.00)29.6817
2010's2 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 88.31

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index88.31 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.54 (4.65)
Search Engine Demand Index153.09 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (88.31)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (7.14%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (92.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]